Alytas Therapeutics
Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
alytas therapeutics GmbH is a spin-off of the University Hospital Jena with the mission to develop novel antibody-based therapeutic concepts for the treatment of morbid obesity (adiposity). Obesity is one of the greatest risk factors for human health and mental well-being in the 21st century (Robert Koch Institute).
AntibodiesBiologics